Gonad Dose Assessment of Patients Undergoing Pelvic Radiotherapy

Introduction: Radiotherapy can impact on patients’ reproductive organs and fertility. This study aims (i) to assess whether the doses to the gonads of 70 patients met the tolerance doses used in radiotherapy planning; (ii) to compare Three-Dimensional Conformal Radiotherapy (3DCRT) with Volumetric M...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniela Ribeiro, Ana Cravo Sá, Elisabete Carolino, Leonor Santos Martins, Margarida Borrego
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/15/13/7000
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849429104448765952
author Daniela Ribeiro
Ana Cravo Sá
Elisabete Carolino
Leonor Santos Martins
Margarida Borrego
author_facet Daniela Ribeiro
Ana Cravo Sá
Elisabete Carolino
Leonor Santos Martins
Margarida Borrego
author_sort Daniela Ribeiro
collection DOAJ
description Introduction: Radiotherapy can impact on patients’ reproductive organs and fertility. This study aims (i) to assess whether the doses to the gonads of 70 patients met the tolerance doses used in radiotherapy planning; (ii) to compare Three-Dimensional Conformal Radiotherapy (3DCRT) with Volumetric Modulated Arc Therapy (VMAT) techniques; and (iii) to verify if ovarian transposition reduces the dose to the ovaries. Methods: A retrospective analysis of 70 patients aged 45 or under who underwent pelvic radiotherapy between 2014 and 2023 in a radiotherapy department was carried out. The dose constraints considered were derived from the Dose-Volume Constraints for Organs at Risk in Radiotherapy project. Results: The average number of children of all the patients in the study was 1.25 and the standard deviation was 1.40. No statistically significant differences were detected regarding the doses to the left and right gonads between 3DCRT and VMAT (<i>p</i> > 0.05). There were statistically significant differences between female patients who underwent ovarian transposition and those who did not undergo ovarian transposition regarding the maximum and medium doses in both right and left ovaries (<i>p</i> < 0.05), with a dose reduction that could reduce doses by an average of up to 39 Gy. Conclusions: In the total sample, 58.6% of patients were treated with VMAT, only 18.6% met the maximum dose limits, and 22.9% met the average dose constraints. Only five women underwent ovarian transposition, which proved effective in meeting dose constraints and significantly reducing the dose to the ovaries.
format Article
id doaj-art-dfec7bb98b4b43888203286c757eedcd
institution Kabale University
issn 2076-3417
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj-art-dfec7bb98b4b43888203286c757eedcd2025-08-20T03:28:28ZengMDPI AGApplied Sciences2076-34172025-06-011513700010.3390/app15137000Gonad Dose Assessment of Patients Undergoing Pelvic RadiotherapyDaniela Ribeiro0Ana Cravo Sá1Elisabete Carolino2Leonor Santos Martins3Margarida Borrego4Radiotherapy Department, Coimbra Local Health Unit, Praceta Prof. Mota Pinto, 3000-075 Coimbra, PortugalRadiotherapy Department, Escola Superior de Saúde do Politécnico do Porto, 4200-072 Porto, PortugalDepartamento das Ciências Exatas, da Vida, Sociais e Humanas, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Av. Dom João II Lote 4.69 01, 1990-096 Lisboa, PortugalRadiotherapy Department, Coimbra Local Health Unit, Praceta Prof. Mota Pinto, 3000-075 Coimbra, PortugalRadiotherapy Department, Coimbra Local Health Unit, Praceta Prof. Mota Pinto, 3000-075 Coimbra, PortugalIntroduction: Radiotherapy can impact on patients’ reproductive organs and fertility. This study aims (i) to assess whether the doses to the gonads of 70 patients met the tolerance doses used in radiotherapy planning; (ii) to compare Three-Dimensional Conformal Radiotherapy (3DCRT) with Volumetric Modulated Arc Therapy (VMAT) techniques; and (iii) to verify if ovarian transposition reduces the dose to the ovaries. Methods: A retrospective analysis of 70 patients aged 45 or under who underwent pelvic radiotherapy between 2014 and 2023 in a radiotherapy department was carried out. The dose constraints considered were derived from the Dose-Volume Constraints for Organs at Risk in Radiotherapy project. Results: The average number of children of all the patients in the study was 1.25 and the standard deviation was 1.40. No statistically significant differences were detected regarding the doses to the left and right gonads between 3DCRT and VMAT (<i>p</i> > 0.05). There were statistically significant differences between female patients who underwent ovarian transposition and those who did not undergo ovarian transposition regarding the maximum and medium doses in both right and left ovaries (<i>p</i> < 0.05), with a dose reduction that could reduce doses by an average of up to 39 Gy. Conclusions: In the total sample, 58.6% of patients were treated with VMAT, only 18.6% met the maximum dose limits, and 22.9% met the average dose constraints. Only five women underwent ovarian transposition, which proved effective in meeting dose constraints and significantly reducing the dose to the ovaries.https://www.mdpi.com/2076-3417/15/13/7000gonad doseovarian transpositionpelvic radiotherapy
spellingShingle Daniela Ribeiro
Ana Cravo Sá
Elisabete Carolino
Leonor Santos Martins
Margarida Borrego
Gonad Dose Assessment of Patients Undergoing Pelvic Radiotherapy
Applied Sciences
gonad dose
ovarian transposition
pelvic radiotherapy
title Gonad Dose Assessment of Patients Undergoing Pelvic Radiotherapy
title_full Gonad Dose Assessment of Patients Undergoing Pelvic Radiotherapy
title_fullStr Gonad Dose Assessment of Patients Undergoing Pelvic Radiotherapy
title_full_unstemmed Gonad Dose Assessment of Patients Undergoing Pelvic Radiotherapy
title_short Gonad Dose Assessment of Patients Undergoing Pelvic Radiotherapy
title_sort gonad dose assessment of patients undergoing pelvic radiotherapy
topic gonad dose
ovarian transposition
pelvic radiotherapy
url https://www.mdpi.com/2076-3417/15/13/7000
work_keys_str_mv AT danielaribeiro gonaddoseassessmentofpatientsundergoingpelvicradiotherapy
AT anacravosa gonaddoseassessmentofpatientsundergoingpelvicradiotherapy
AT elisabetecarolino gonaddoseassessmentofpatientsundergoingpelvicradiotherapy
AT leonorsantosmartins gonaddoseassessmentofpatientsundergoingpelvicradiotherapy
AT margaridaborrego gonaddoseassessmentofpatientsundergoingpelvicradiotherapy